Boston Scientific vs GE HealthCare
Boston Scientific and GE HealthCare are similar in size: $20.07bn and $20.63bn of revenue in their latest fiscal years. Boston Scientific grew faster (19.9% against 4.8%). Boston Scientific kept more of each dollar of sales as profit: a net margin of 14.4% against 10.1%. Boston Scientific carries less debt relative to equity (47.2% against 101.3%).
| Latest fiscal year | Boston ScientificBSX, 2025 | GE HealthCareGEHC, 2025 |
|---|---|---|
| Revenue | $20.07bn | $20.63bn |
| Revenue growth | 19.9% | 4.8% |
| Net income | $2.90bn | $2.08bn |
| Operating margin | 18.0% | 13.4% |
| Net margin | 14.4% | 10.1% |
| Return on equity | 12.6% | 22.1% |
| Free cash flow | $3.66bn | $1.50bn |
| Cash | $1.97bn | $4.49bn |
| Total debt | $11.44bn | $10.51bn |
| Debt to equity | 47.2% | 101.3% |
| Dividend per share | — | $0.14 |
| Dividend yield | — | 0.2% |
| Share buybacks | — | $200m |
| Employees | 59,000 | 54,000 |
| Market value | $63.03bn | $36.36bn |
| Price vs our value range | Within our value range | Above our value range |
| Moat score | 73 (Strong) | — |
| Insider trades, 12 months | 10 buys, 7 sales | 8 buys, 0 sales |